SJP-0035

unknown · Senju Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SJP-0035, covering 2018-06-12 to 2021-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders [Phase 2]

See pricing